Myelodysplastic Syndromes (mds) - Epidemiology

Relevant Publications

Molecular Taxonomy of Myelodysplastic Syndromes and its Clinical Implications.

Issue Release: 2024

Alloimmunization in myelodysplastic syndrome is associated with higher healthcare costs, longer hospitalizations, and increased mortality.

Issue Release: 2024

Early transfusion patterns improve the Molecular International Prognostic Scoring System (IPSS-M) prediction in myelodysplastic syndromes.

Issue Release: 2024

Molecular and clinical presentation of UBA1-mutated myelodysplastic syndromes.

Issue Release: 2024

Comparison of cytomorphology and histomorphology in myelodysplastic syndromes.

Issue Release: 2024

Highly immunosuppressive myeloid cells correlate with early relapse after allogeneic stem cell transplantation.

Issue Release: 2024

Venetoclax, a new player in the treatment of children with high-risk myeloid malignancies?

Issue Release: 2024

Enhanced ALOX12 Gene Expression Predicts Therapeutic Susceptibility to 5-Azacytidine in Patients with Myelodysplastic Syndromes.

Issue Release: 2024

Dysregulated innate immune signaling cooperates with RUNX1 mutations to transform an MDS-like disease to AML.

Issue Release: 2024

The der(1;7)(q10;p10) defining a distinct profile from -7/del(7q) in myelodysplastic syndromes: A systematic review and meta-analysis.

Issue Release: 2024

Splicing modulators impair DNA damage response and induce killing of cohesin-mutant MDS and AML.

Issue Release: 2024

Outcomes and effect of somatic mutations after erythropoiesis stimulating agents in patients with lower-risk myelodysplastic syndromes.

Issue Release: 2024

Diagnostic Value of Serum Adenosine Deaminase in Myelodysplastic Syndromes: an Observational Study.

Issue Release: 2024

Efficacy of Yisui granule on myelodysplastic syndromes in SKM-1 mouse xenograft model through suppressing Wnt/β-catenin signaling pathway.

Issue Release: 2024

The role of genetic factors in pediatric myelodysplastic syndromes with different outcomes.

Issue Release: 2024

Cytogenetic and molecular associations with outcomes in HR-MDS treated with hypomethylating agents plus venetoclax.

Issue Release: 2024

Applications of Circulating Tumor DNA in Myelodysplastic Syndromes and Acute Myeloid Leukemia: Promises and Challenges.

Issue Release: 2024

PARP inhibitor maintenance treatment for newly diagnosed ovarian cancer patients: a real-world study from China.

Issue Release: 2024

EXPRESS: A new therapeutic perspective: erastin inhibits tumor progression by driving ferroptosis in myelodysplastic syndromes.

Issue Release: 2024

Outcomes with Allogeneic Hematopoietic Stem Cell Transplantation in TP53-mutated Myelodysplastic syndrome: A Systematic Review and Meta-Analysis.

Issue Release: 2024

What are the Consequences of Overusing Jargon?

Why are Emerging Health Threats Important?

Can Free Transportation Reduce Health Disparities?

Why is Salt Important in Epidemiology?

How do limitations in software impact epidemiological research?

Why Are Protective Measures Important?

How Does Renewable Energy Impact Public Health?

What Role Does Environment Play in Transmission?

What Prevention Strategies Exist?

Can Human Activities Alter Ecological Interactions?

Partnered Content Networks

Relevant Topics